UpStream Bio Inc.

UPB12 Jan 2025
Healthcare
$15.51
-0.15 (-15.38%)
Lowest Today
$13.53
Highest Today
$15.51
Today’s Open
$15.51
Prev. Close
$16.19
52 Week High
$29.46
52 Week Low
$13.42
To Invest in UpStream Bio Inc.

UpStream Bio Inc.

Healthcare
UPB12 Jan 2025
-0.15 (-15.38%)
1M
3M
6M
1Y
5Y
Low
$13.53
Day’s Range
High
$15.51
13.53
52 Week Low
$13.42
52-Week Range
52 Week High
$29.46
13.42
1 Day
-
1 Week
-19.39%
1 month return
-31.27%
3 month return
-41.5%
6 month return
-38%
1 Year return
-38%
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
0
PB Ratio
0
PE Ratio
0
Enterprise Value
0
Total Assets
117.2 mln
Volume

Fund house & investment objective

Company Information
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
Organisation
UpStream Bio Inc.
Employees
0
Industry
Biotechnology
CEO
Dr. E. Rand Sutherland M.D., M.P.H., MPH
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities